Plain-English translation of NCT06515093 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This trial is testing two new products designed to help heal chronic wounds: PelloGraft for diabetic foot ulcers and SanoGraft for venous leg ulcers. Researchers want to see how well these treatments work compared to the standard care patients normally receive. The study will track how quickly wounds heal and how many applications of the new treatment are needed.
Many people with diabetic foot ulcers and venous leg ulcers struggle with slow or incomplete healing, which can lead to serious complications. This trial will help insurance companies and healthcare systems decide whether to cover and pay for these newer treatment options.
You likely qualify if…
You likely don't qualify if…
You will be randomly assigned to receive either the new wound treatment or standard care. You'll visit the study clinic regularly so doctors can measure your wound size, check healing progress, and count how many treatment applications you receive. The study will follow your wound healing over time to see which approach works better.
AI-generated summary from trial data · Jul 13, 2026 · Not medical advice
United States